Llemit, Junalito .

HRN: 19-67-47  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2022
CEFUROXIME 1.5GM (VIAL)
12/28/2022
01/03/2023
IVT
1.5g
Q8
UTI
Waiting Final Action 
01/01/2023
CEFUROXIME 500MG (TAB)
01/01/2023
01/05/2023
PO
500mg
BID
UTI
Waiting Final Action 
01/04/2023
CEFUROXIME 1.5GM (VIAL)
01/04/2023
01/11/2023
IVT
1.5grams
Q8h
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: